Bayesian bivariate meta-analysis of correlated effects: Impact of the prior distributions on the between-study correlation, borrowing of strength, and joint inferences

Statistical Methods in Medical Research

Volumn 27, Issue 2, 2018, Pages 428-450

  Burke, Danielle L ^a   Bujkiewicz, Sylwia ^b   Riley, Richard D ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Bayes; bivariate multivariate meta analysis; correlation; multiple outcomes; prior distributions; simulation study

Indexed keywords

ARTICLE; BAYES THEOREM; BIVARIATE ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; COVARIANCE; MEASUREMENT ACCURACY; META ANALYSIS (TOPIC); NORMAL DISTRIBUTION; PREDICTOR VARIABLE; PROBABILITY; RANDOMIZATION; SIMULATION; STATISTICAL DISTRIBUTION; UNCERTAINTY; UNIVARIATE ANALYSIS; VARIANCE; BIOSTATISTICS; COMPUTER SIMULATION; HUMAN; META ANALYSIS; MULTIVARIATE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL; TREATMENT OUTCOME;

BAYES THEOREM; BIOSTATISTICS; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; HUMANS; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; TREATMENT OUTCOME;

EID: 85041945694     PISSN: 09622802     EISSN: 14770334     Source Type: Journal    
DOI: 10.1177/0962280216631361     Document Type: Article

References (44)

1. Riley RD. Multivariate meta-analysis: the effect of ignoring within-study correlation. J R Stat Soc A 2009; 172: 789–811.
2. Jackson D, Riley R, White IR. Multivariate meta-analysis: potential and promise. Stat Med 2011; 30: 2481–2498.
3. Riley RD, Thompson JR, Abram KR. An alternative model for bivariate random-effects meta-analysis when the within-study correlations are unknown. Biostatistics 2008; 9: 172–186.
4. Mavridis D, Salanti G. A practical introduction to multivariate meta-analysis. Stat Methods Med Res 2013; 22: 133–158.
5. Riley RD, Abrams KR, Lambert PC, An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes. Stat Med 2007; 26: 78–97.
6. Kirkham JJ, Riley RD, Williamson PR. A multivariate meta-analysis approach for reducing the impact of outcome reporting bias in systematic reviews. Stat Med 2012; 31: 2179–2195.
7. Jackson D, White IR, Price M, Borrowing of strength and study weights in multivariate and network meta-analysis. Stat Methods Med Res 2017; 26: 2853–2868.
8. Lambert PC, Sutton AJ, Burton PR, How vague is vague? A simulation study of the impact of the use of prior distributions in MCMC using WinBUGS. Stat Med 2005; 24: 2401–2428.
9. Rhodes KM, Turner RM, Higgins JP. Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data. J Clin Epidemiol 2014; 68: 52–60.
10. Turner RM, Davey J, Clarke MJ, Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol 2012; 41: 818–827.
11. Pullenayegum EM. An informed reference prior for between-study heterogeneity in meta-analyses of binary outcomes. Stat Med 2011; 30: 3082–3094.
12. Riley RD, Dodd SR, Craig JV, Meta-analysis of diagnostic test studies using individual patient data and aggregate data. Stat Med 2008; 27: 6111–6136.
13. Zwinderman AH, Bossuyt PM. We should not pool diagnostic likelihood ratios in systematic reviews. Stat Med 2008; 27: 687–697.
14. Bujkiewicz S, Thompson JR, Spata E, Uncertainty in the Bayesian meta-analysis of normally distributed surrogate endpoints. Stat Methods Med Res 2017; 26: 2287–2318.
15. Leonard TH, Hsu JS. Bayesian inference for a covariance matrix. Ann Stat 1992; 20: 1669–1696.
16. Daniels MJ, Robert EK. Nonconjugate Bayesian estimation of covariance matrices and its use in hierarchical models. J Am Stat Assoc 1999; 94: 1254–1263.
17. Wei Y, Higgins JPT. Bayesian multivariate meta-analysis with multiple outcomes. Stat Med 2013; 32: 1191–1205.
18. Nam IS, Mengersen K, Garthwaite P. Multivariate meta-analysis. Stat Med 2003; 22: 2309–2333.
19. Reitsma JB, Glas AS, Rutjes AW, Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005; 58: 982–990.
20. Snell KI, Hua H, Debray TP, Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model. J Clin Epidemiol 2016; 69: 40–50.
21. Bujkiewicz S, Thompson JR, Sutton AJ, Multivariate meta-analysis of mixed outcomes: a Bayesian approach. Stat Med 2013; 32: 3926–3943.
22. Bujkiewicz S, Thompson JR, Riley RD, Bayesian meta-analytical methods to incorporate multiple surrogate endpoints in drug development process. Stat Med 2016; 35: 1063–1089.
23. Riley RP, Price MJ, Jackson D, Multivariate meta-analysis using individual participant data. Res Synth Meth 2015; 6: 157–174.
24. Trikalinos TA, Hoaglin DC, Schmid CH. An empirical comparison of univariate and multivariate meta-analyses for categorical outcomes. Stat Med 2014; 33: 1441–1459.
25. Wei Y, Higgins JPT. Estimating the within-study covariances in multivariate meta-analysis with multiple outcomes. Stat Med 2013; 32: 1191–1205.
26. Gelman A. Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper). Bayesian Anal 2006; 1: 515–515.
27. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian approaches to clinical trials and health-care evaluation, Chichester: John Wiley & Sons, 2004.
28. Neuenschwander B, Capkun-Niggli G, Branson M, Summarizing historical information on controls in clinical trials. Clin Trials 2010; 7: 5–18.
29. Higgins JP, Whitehead A. Borrowing strength from external trials in a meta-analysis. Stat Med 1996; 15: 2733–2749.
30. Menke J. Bayesian bivariate meta-analysis of sensitivity and specificity: summary of quantitative findings in 50 meta-analyses. J Eval Clin Pract 2014; 20: 844–852.
31. Yang B, Shi J, Chen X, Efficacy and safety of therapies for acute ischemic stroke in China: a network meta-analysis of 13289 patients from 145 randomized controlled trials. PLoS ONE 2014; 9(2): e88440–e88440.
32. Jansen JP. Network meta-analysis of survival data with fractional polynomials. BMC Med Res Methodol 2011; 11: 61–61.
33. Riley RD, Abrams KR, Sutton AJ, Bivariate random-effects meta-analysis and the estimation of between-study correlation. BMC Med Res Methodol 2007; 7: 3–3.
34. Smyth RM, Kirkham JJ, Jacoby A, Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ 2011; 342: c7153–c7153.
35. Saini P, Loke YK, Gamble C, Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews. BMJ 2014; 349: g6501–g6501.
36. Frosi G, Riley RD, Williamson PR, Multivariate meta-analysis helps examine the impact of outcome reporting bias in Cochrane rheumatoid arthritis reviews. J Clin Epidemiol 2015; 68(5): 542–550.
37. Inc SI. SAS/STAT® 9.3 user’s guide, Cary, NC: SAS Institute Inc, 2011.
38. Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc A 2009; 172(Part 1): 137–159.
39. Symons MJ, Moore DT. Hazard rate ratio and prospective epidemiological studies. J Clin Epidemiol 2002; 55(9): 893–899.
40. Perneger TV. Estimating the relative hazard by the ratio of logarithms of event-free proportions. Contemp Clin Trials 2008; 29(5): 762–766.
41. Achana FA, Cooper NJ, Bujkiewicz S, Network meta-analysis of multiple outcome measures accounting for borrowing of information across outcomes. BMC Med Res Methodol 2014; 14: 92–92.
42. Gajic-Veljanoski O, Cheung AM, Bayoumi AM, A tutorial on Bayesian bivariate meta-analysis of mixed binary-continuous outcomes with missing treatment effects. Stat Med 2016; 35: 2092–2108.
43. Senn S. Trying to be precise about vagueness. Stat Med 2007; 26(7): 1417–1430.
44. Lambert PC, Sutton AJ, Burton PR, Comments on ‘trying to be precise about vagueness’ by Stephen Senn, Statistics in Medicine 2007; 26:1417–1430. Stat Med 2008; 27(4): 619–619. (author reply 22–24).